Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

October 2022; Volume 42,Issue 10

Reviews

  • Open Access
    Hyperthermic Intraperitoneal Chemotherapy in the Management of Primary Epithelial Ovarian Cancer: A Debated Issue for Gynecologic Oncologists
    ANGIOLO GADDUCCI, STEFANIA COSIO and PIERO VINCENZO LIPPOLIS
    Anticancer Research October 2022, 42 (10) 4659-4665; DOI: https://doi.org/10.21873/anticanres.15970
  • Open Access
    Pathophysiology and Therapeutic Perspectives for Chemotherapy-induced Peripheral Neuropathy
    ANTONIO AVALLONE, SABRINA BIMONTE, CLAUDIA CARDONE, MARCO CASCELLA and ARTURO CUOMO
    Anticancer Research October 2022, 42 (10) 4667-4678; DOI: https://doi.org/10.21873/anticanres.15971

Experimental Studies

  • Open Access
    Recombinant Thrombomodulin Has Anti-tumor Effects and Enhances the Effects of Gemcitabine for Pancreatic Cancer Through G-protein Coupled Receptor 15
    KENEI FURUKAWA, JIANHUA LING, YICHEN SUN, YU LU, JIE FU, RUI MARUKUCHI and PAUL J. CHIAO
    Anticancer Research October 2022, 42 (10) 4679-4687; DOI: https://doi.org/10.21873/anticanres.15972
  • You have access
    Microtumor Spheroids Provide a Model for Studying Molecules Involved in Vascular Organization: An Illustrative Study for VE-cadherin
    PAUL DEMBÉLÉ, OLIVIA GARNIER, DONALD K. MARTIN and ISABELLE VILGRAIN
    Anticancer Research October 2022, 42 (10) 4689-4700; DOI: https://doi.org/10.21873/anticanres.15973
  • You have access
    PRKRIP1, A Splicing Complex Factor, Is a Marker of Poor Prognosis in Colorectal Cancer
    YUKI OZATO, TAKAAKI MASUDA, YUTA KOBAYASHI, SEIICHIRO TAKAO, YUUICHI HISAMATU, TAKEO TOSHIMA, YUSUKE YONEMURA, MAMORU UEMURA, HIDETOSHI EGUCHI, YUICHIRO DOKI, MASAKI MORI and KOSHI MIMORI
    Anticancer Research October 2022, 42 (10) 4701-4706; DOI: https://doi.org/10.21873/anticanres.15974
  • Open Access
    Long-chain Non-coding RNA MIR4435-2HG Expression Correlates With Size of Intestinal Polyps in Children and With Metastasis of Colon Cancer
    DANRONG ZHU, PIAO GUO, XIN YU JIN, RONG ZHANG, GUOZHONG JI, ZHIJIAN YANG, ROBERT M. HOFFMAN and WEISONG SHENG
    Anticancer Research October 2022, 42 (10) 4707-4714; DOI: https://doi.org/10.21873/anticanres.15975
  • Open Access
    Micro RNA miR-1303 Promotion of Proliferation, Migration and Invasion of Human Liver Cancer Cells Is Enhanced by Low Talin 1 (TLN1) Expression
    JUN HUANG, QINGYUAN XI, JIE XIONG, HAO PENG, HAITAO YANG, YU SUN and ROBERT M. HOFFMAN
    Anticancer Research October 2022, 42 (10) 4715-4725; DOI: https://doi.org/10.21873/anticanres.15976
  • You have access
    CEP-1347 Targets MDM4 Protein Expression to Activate p53 and Inhibit the Growth of Glioma Cells
    YUTA MITOBE, YURIKA NAKAGAWA-SAITO, KEITA TOGASHI, SHUHEI SUZUKI, ASUKA SUGAI, KEN-ICHIRO MATSUDA, YUKIHIKO SONODA, CHIFUMI KITANAKA and MASASHI OKADA
    Anticancer Research October 2022, 42 (10) 4727-4733; DOI: https://doi.org/10.21873/anticanres.15977
  • You have access
    β-Tubulin Isoforms Related to Docetaxel Sensitivity in 2D and 3D Cultured TNBC Cell Lines
    MASAKO MUGURUMA, MARIKO ASAOKA, SAEKO TERAOKA, KANA MIYAHARA, TAKAHIKO KAWATE and TAKASHI ISHIKAWA
    Anticancer Research October 2022, 42 (10) 4735-4742; DOI: https://doi.org/10.21873/anticanres.15978
  • You have access
    The CGRP Receptor Antagonist MK0974 Induces EVI1high AML Cell Apoptosis by Disrupting ERK Signaling
    AKIRA SUEKANE, TOMONAGA ICHIKAWA, YUSUKE SAITO, SHINGO NAKAHATA and KAZUHIRO MORISHITA
    Anticancer Research October 2022, 42 (10) 4743-4752; DOI: https://doi.org/10.21873/anticanres.15979
  • You have access
    Kruppel-like Factor 2 Inhibits Proliferation in Renal Angiomyolipoma via IL-6/JAK/STAT3 Signaling Pathway
    CHUNG-YI LIU, TZU-HSUAN CHANG, CHIN-HSUAN HSIEH, YING-HSU CHANG, JACOB SEE-TONG PANG and CHENG-KENG CHUANG
    Anticancer Research October 2022, 42 (10) 4753-4762; DOI: https://doi.org/10.21873/anticanres.15980
  • You have access
    The Complex Composition of Trans-resveratrol, Quercetin, Vitamin E and Selenium Inhibits the Growth of Colorectal Carcinoma
    JUSTYNA CZAPLA, ALINA DRZYZGA, SYBILLA MATUSZCZAK, EWELINA PILNY, TOMASZ CICHOŃ, KRZYSZTOF STOJECKI and RYSZARD SMOLARCZYK
    Anticancer Research October 2022, 42 (10) 4763-4772; DOI: https://doi.org/10.21873/anticanres.15981

Clinical Studies

  • Open Access
    Retrospective Analysis of Treatment Pathways in Patients With BRAFV600E-mutant Metastatic Colorectal Carcinoma – MORSECRC
    ARMIN GERGER, WOLFGANG EISTERER, STEFAN FUXIUS, SARA BASTIAN, DIETER KOEBERLE, MANFRED WELSLAU, DILARA AKHOUNDOVA SANOYAN, CHRISTIAN MAAS, JENS UHLIG, KLAUS FENCHEL, RICHARD GREIL, EYCK VON DER HEYDE, GAËLLE RHYNER AGOCS, RUDOLF WEIDE, MONIKA SCHWAGER, FRANK REICHENBACH, DOMINIK PAUL MODEST and RALPH FRITSCH
    Anticancer Research October 2022, 42 (10) 4773-4785; DOI: https://doi.org/10.21873/anticanres.15982
  • Open Access
    Surgical Administration of Indocyanine Green in Hepatectomy for Improved Bile Leakage Detection
    TAKEHIKO HANAKI, KEISUKE GOTO, MASAKI MORIMOTO, YUKI MURAKAMI, TOMOYUKI MATSUNAGA, MANABU YAMAMOTO, NARUO TOKUYASU, TERUHISA SAKAMOTO, TOSHIMICHI HASEGAWA and YOSHIYUKI FUJIWARA
    Anticancer Research October 2022, 42 (10) 4787-4793; DOI: https://doi.org/10.21873/anticanres.15983
  • You have access
    Long-term Local Control and Overall Survival After Radiotherapy in Oligoprogressive Patients During Treatment With Checkpoint Inhibitors
    PIM J.J. DAMEN, KARIJN P.M. SUIJKERBUIJK, ANNE S.R. VAN LINDERT, WIETSE S.C. EPPINGA, SHERIF Y. EL SHAROUNI and JOOST J.C. VERHOEFF
    Anticancer Research October 2022, 42 (10) 4795-4804; DOI: https://doi.org/10.21873/anticanres.15984
  • You have access
    Efficacy of Chemoimmunotherapy in NSCLC Patients With Brain Metastasis With or Without Prior Brain Radiotherapy
    YUSUKE TAKAYAMA, JUN YANO, REN SEIKE, SHOHEI MISHIMA and HIROYASU SHODA
    Anticancer Research October 2022, 42 (10) 4805-4812; DOI: https://doi.org/10.21873/anticanres.15985
  • Open Access
    Total Lesion Glycolysis Levels as Predictive Indicators in Patients With Metastatic and Recurrent Breast Cancer Undergoing Endocrine Therapy With or Without CDK4/6 Inhibitor
    HIROMI OZAWA, TOMOKO HIGUCHI, YUKIE FUJIMOTO, AYAKO BUN, REIKO FUKUI, HARUKA KANAOKA, MASAYUKI NAGAHASHI, KAZUHIRO KITAJIMA, KOICHIRO YAMAKADO and YASUO MIYOSHI
    Anticancer Research October 2022, 42 (10) 4813-4824; DOI: https://doi.org/10.21873/anticanres.15986
  • You have access
    Tumor Load Matters – the Peritoneal Cancer Index in Patients With High-grade Serous Ovarian Cancer
    EVA EGGER, FREYA MERKER, DAMIAN J. RALSER, MATEJA CONDIC, MILKA MARINOVA, MICHAEL MUDERS, MATTHIAS STOPE and ALEXANDER MUSTEA
    Anticancer Research October 2022, 42 (10) 4825-4831; DOI: https://doi.org/10.21873/anticanres.15987
  • You have access
    Outcomes and Side Effects of Preoperative Chemoradiotherapy for Locally Advanced Upper Rectal Cancer
    SANDRA CHOMICKI, SOPHIE CHAPET, MOUSSATA DRIFA, MEHDI OUAISSI, PASCAL BOURLIER, KAMEL DEBBI, GOKOULAKRICHENANE LOGANADANE and GILLES CALAIS
    Anticancer Research October 2022, 42 (10) 4833-4840; DOI: https://doi.org/10.21873/anticanres.15988
  • You have access
    Relationship Between Fat Mass Indices and Postoperative Complications After Laparoscopic Gastrectomy in Patients With Gastric Cancer: A Propensity Score Matching Analysis
    RYOTA MATSUI, NORIYUKI INAKI, TOSHIKATSU TSUJI and TETSU FUKUNAGA
    Anticancer Research October 2022, 42 (10) 4841-4848; DOI: https://doi.org/10.21873/anticanres.15989
  • You have access
    Intraoperative Holographic Guidance Using Virtual Reality and Mixed Reality Technology During Laparoscopic Colorectal Cancer Surgery
    SHUNJIN RYU, TAKAHIRO KITAGAWA, KEISUKE GOTO, ATSUKO OKAMOTO, RUI MARUKUCHI, KEIGO HARA, RYUSUKE ITO and YUKIO NAKABAYASHI
    Anticancer Research October 2022, 42 (10) 4849-4856; DOI: https://doi.org/10.21873/anticanres.15990
  • You have access
    Efficacy of Novel Hormone Agents in the Treatment of Metastatic Castration-resistant Prostate Cancer: A Real-world Retrospective Study
    JIAN-RI LI, SHIAN-SHIANG WANG, CHUAN-SHU CHEN, CHENG-KUANG YANG, KEVIN LU, CHEN-LI CHENG, SHENG-CHUN HUNG, SHU-YEN CHEN, CHIANN YI HSU and KUN-YUAN CHIU
    Anticancer Research October 2022, 42 (10) 4857-4866; DOI: https://doi.org/10.21873/anticanres.15991
  • You have access
    Absolute Lymphocyte Count Is an Independent Prognostic Factor for ER-positive HER2-negative Advanced Breast Cancer Patients Treated With CDK4/6 Inhibitors
    HARUKA KANAOKA, MASAYUKI NAGAHASHI, YUSA ATAKE, AKIRA HATTORI, AYAKO BUN, REIKO FUKUI, HIROMI OZAWA, YUKIE FUJIMOTO, TOMOKO HIGUCHI, KEIKO NATORI, MICHIKO IMAMURA, KEIKO MURASE, YUICHI TAKATSUKA and YASUO MIYOSHI
    Anticancer Research October 2022, 42 (10) 4867-4878; DOI: https://doi.org/10.21873/anticanres.15992
  • You have access
    Simultaneous Detection and HER2 Profiling of Circulating Breast Cancer Cells in Clinical Patients Using a Rare Cell Sorter
    TOMOKO MORI, ATSUKO FURUKAWA, TURAN BILAL, AYA UEDA, HIROKO BANDO, TAISUKE MASUDA, FUMIHITO ARAI and SATOSHI MATSUSAKA
    Anticancer Research October 2022, 42 (10) 4879-4886; DOI: https://doi.org/10.21873/anticanres.15993
  • You have access
    Sarcopenia Is an Independent Prognostic Factor for Squamous Cell Carcinoma of the Cervix Treated With Concurrent Chemoradiotherapy
    SHINYU KISE, YOSHIHISA ARAKAKI, WATARU KUDAKA, TAKURO ARIGA, NAGISA KINJO, HIROSHI KOHATU and YOICHI AOKI
    Anticancer Research October 2022, 42 (10) 4887-4893; DOI: https://doi.org/10.21873/anticanres.15994
  • You have access
    Leaky Gut and Severe Adverse Events in Advanced Hepatocellular Carcinoma Treated With Lenvatinib
    YUKI FUJIMOTO, TADASHI NAMISAKI, SOICHI TAKEDA, KOJI MURATA, MASAHIDE ENOMOTO, HIROAKI TAKAYA, YUKI TSUJI, YUKIHISA FUJINAGA, YASUHIKO SAWADA, NORIHISA NISHIMURA, KOH KITAGAWA, KOSUKE KAJI, TAKASHI INOUE, HIDETO KAWARATANI, KEI MORIYA, TAKEMI AKAHANE, AKIRA MITORO and HITOSHI YOSHIJI
    Anticancer Research October 2022, 42 (10) 4895-4905; DOI: https://doi.org/10.21873/anticanres.15995
  • You have access
    Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
    TAKURO OKADA, TAKASHI MATSUKI, CHIHIRO FUSHIMI, ISAKU OKAMOTO, HIROKI SATO, TAKAHITO KONDO, KUNIHIKO TOKASHIKI, TATSUYA ITO, TATSUO MASUBUCHI, YUICHIRO TADA, KOUKI MIURA, KENJI HANYU, GO OMURA, HIDEKI TAKAHASHI, TAKU YAMASHITA, NOBUHIKO ORIDATE and KIYOAKI TSUKAHARA
    Anticancer Research October 2022, 42 (10) 4907-4912; DOI: https://doi.org/10.21873/anticanres.15996
  • You have access
    Awake Breast Conservative Surgery: A Strategy to Shorten Surgical Waiting Lists During and Post COVID-19 Emergency
    GIANLUCA VANNI, MARCO PELLICCIARO, MARCO MATERAZZO, JONATHAN CASPI, MARCELLO CHIOCCHI, FEDERICO TACCONI, ANNALISA NOCE, GIANLUCA NICOLAI, ILARIA PORTARENA, CHIARA BUONOMO, DAURI MARIO and ORESTE CLAUDIO BUONOMO
    Anticancer Research October 2022, 42 (10) 4913-4919; DOI: https://doi.org/10.21873/anticanres.15997
  • You have access
    Efficacy and Safety of Paclitaxel/nab-paclitaxel Chemotherapy for Patients With Relapsed Small Cell Lung Cancer
    YOHEI MATSUI, TADAAKI YAMADA, KENJI MORIMOTO, YUKI KATAYAMA, OSAMU HIRANUMA, SHINSUKE SHIOTSU, NOBUYO TAMIYA, TAKAYUKI TAKEDA, YOSHIE MORIMOTO, MASAHIRO IWASAKU, SHINSAKU TOKUDA and KOICHI TAKAYAMA
    Anticancer Research October 2022, 42 (10) 4921-4928; DOI: https://doi.org/10.21873/anticanres.15998
  • You have access
    Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-RT) for Patients With Potentially Resectable Esophageal Cancer
    MAKOTO SAKAI, MAKOTO SOHDA, SHINTARO UCHIDA, ARISA YAMAGUCHI, TAKAYOSHI WATANABE, HIDEYUKI SAITO, YASUNARI UBUKATA, NOBUHIRO NAKAZAWA, KENGO KURIYAMA, AKIHIKO SANO, HIROOMI OGAWA, TAKEHIKO YOKOBORI, SHIN-EI NODA, TATSUYA OHNO, KEN SHIRABE and HIROSHI SAEKI
    Anticancer Research October 2022, 42 (10) 4929-4935; DOI: https://doi.org/10.21873/anticanres.15999
  • You have access
    Comparison of Survival Outcomes Based on Pre-treatment Pleural Effusion in Advanced Epithelial Ovarian Cancer
    JUHUN LEE and DAE GY HONG
    Anticancer Research October 2022, 42 (10) 4937-4943; DOI: https://doi.org/10.21873/anticanres.16000
  • You have access
    Prognostic Significance of Clinical Factors Including BRCA Mutation in Epithelial Ovarian, Peritoneal, Fallopian Tube Cancer
    JI YOUNG KIM, HAEIL PARK, DAE WOO LEE, MIN JEONG KIM, JAE EUN SHIN, KYUNG EUN LEE and HAE NAM LEE
    Anticancer Research October 2022, 42 (10) 4945-4954; DOI: https://doi.org/10.21873/anticanres.16001
  • You have access
    Clinicopathological Characteristics of Advanced Epstein–Barr Virus-associated Gastric Cancer Highlighting Aberrant p53 Expression
    HYEONGUK JANG, AN NA SEO and MOONSIK KIM
    Anticancer Research October 2022, 42 (10) 4955-4962; DOI: https://doi.org/10.21873/anticanres.16002
  • You have access
    Lymphocyte-to-C-Reactive Protein Ratio Predicts Prognosis in Patients With Colorectal Liver Metastases Post-hepatic Resection: A Retrospective Study
    MASASHI UTSUMI, MASARU INAGAKI, KOJI KITADA, NAOYUKI TOKUNAGA, MIDORI KONDO, KOSUKE YUNOKI, YUYA SAKURAI, RYOSUKE HAMANO, HIDEAKI MIYASOU, YOUSUKE TSUNEMITSU and SHINYA OTSUKA
    Anticancer Research October 2022, 42 (10) 4963-4971; DOI: https://doi.org/10.21873/anticanres.16003
  • You have access
    The Effect and Tolerability of Second-line Chemotherapy Are Associated With Disease Control by Nivolumab Chemotherapy in Patients With Gastric Cancer
    HIROSHI MATSUOKA, TOMOHIRO MIZUNO, MINAMI SAKAI, KAZUMITSU SUZUKI, AKIKO SERIZAWA, MASAYA NAKAUCHI, TSUYOSHI TANAKA, SUSUMU SHIBASAKI, TAKAHIRO HAYASHI and KOICHI SUDA
    Anticancer Research October 2022, 42 (10) 4973-4980; DOI: https://doi.org/10.21873/anticanres.16004
  • You have access
    Efficacy and Safety of Radium-223 for Castration-resistant Prostate Cancer With Bone Metastasis Before and After Docetaxel
    KO OKABE, NAOKI TERADA, TATSUYA SHIRAKAWA, CHIE ONIZUKA, TOMOYA KIMURA, YASUHIRO YAMASHITA, ISAMU OTUKA, TAKASHI UENO, MASAFUMI NAGANO, HIROKI TAKAMORI, SHOICHIRO MUKAI and TOSHIYUKI KAMOTO
    Anticancer Research October 2022, 42 (10) 4981-4987; DOI: https://doi.org/10.21873/anticanres.16005
  • You have access
    Combined Inflammation and Nutrition Factors Reinforce the Prognostic Prediction for Stage III Colorectal Cancer Patients
    SHINYA KATO, NORIKATSU MIYOSHI, SHIKI FUJINO, SOICHIRO MINAMI, CHU MATSUDA, MASAYOSHI YASUI, MASAYUKI OHUE, YUKI SEKIDO, TSUYOSHI HATA, TAKAYUKI OGINO, HIDEKAZU TAKAHASHI, MAMORU UEMURA, HIROFUMI YAMAMOTO, YUICHIRO DOKI and HIDETOSHI EGUCHI
    Anticancer Research October 2022, 42 (10) 4989-4999; DOI: https://doi.org/10.21873/anticanres.16006
  • You have access
    Long-term Outcomes and Prognostic Factors of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma
    KAZUYOSHI NAGATA, RYU SASAKI, SHINICHI IWATSU, MASANORI FUKUSHIMA, MASAFUMI HARAGUCHI, SHINOBU YAMAMICHI, SATOSHI MIUMA, HISAMITSU MIYAAKI, NAOTA TAURA, TAKUYA YAMAZAKI and KAZUHIKO NAKAO
    Anticancer Research October 2022, 42 (10) 5001-5007; DOI: https://doi.org/10.21873/anticanres.16007

Vitamin D in Prevention and Therapy and Biologic Effects of Light

  • Open Access
    Preface
    JÖRG REICHRATH, MICHAEL F. HOLICK, MICHAEL FRIEDRICH and THOMAS VOGT
    Anticancer Research October 2022, 42 (10) 5008;
  • Reviews

    • Open Access
      An Appraisal to Address Health Consequences of Vitamin D Deficiency With Food Fortification and Supplements: Time to Act!
      JÖRG REICHRATH, WINFRIED MÄRZ, FRANK R. DE GRUIJL, REINHOLD VIETH, WILLIAM B. GRANT, ANDRZEJ T. SLOMINSKI, MICHAEL F. HOLICK, THOMAS VOGT and STEFAN PILZ
      Anticancer Research October 2022, 42 (10) 5009-5015; DOI: https://doi.org/10.21873/anticanres.16008
    • Open Access
      Counteracting Side-effects of Photodynamic Therapy for Actinic Keratoses
      HANS CHRISTIAN WULF and IDA M. HEERFORDT
      Anticancer Research October 2022, 42 (10) 5017-5020; DOI: https://doi.org/10.21873/anticanres.16009
    • Open Access
      Cutaneous Melanoma: Sheep in Wolves Clothing?
      FRANK R. DE GRUIJL and BRUCE K. ARMSTRONG
      Anticancer Research October 2022, 42 (10) 5021-5025; DOI: https://doi.org/10.21873/anticanres.16010
    • Open Access
      Critique of Public Health Guidance for Vitamin D and Sun Exposure in the Context of Cancer and COVID-19
      REINHOLD VIETH
      Anticancer Research October 2022, 42 (10) 5027-5034; DOI: https://doi.org/10.21873/anticanres.16011
    • Open Access
      Photosynthesis in Plants and Algae
      DONAT-P. HÄDER
      Anticancer Research October 2022, 42 (10) 5035-5041; DOI: https://doi.org/10.21873/anticanres.16012
  • Experimental Studies

    • Open Access
      A Novel Immunomodulatory Mechanism by Which Vitamin D Influences Folate Receptor 3 Expression to Reduce COVID-19 Severity
      ROSY J. LU, PURUSHA SHIRVANI and MICHAEL F. HOLICK
      Anticancer Research October 2022, 42 (10) 5043-5048; DOI: https://doi.org/10.21873/anticanres.16013
    • Open Access
      Cross-talk of Aryl Hydrocarbon Receptor (AHR)- and Vitamin D Receptor (VDR)-signaling in Human Keratinocytes
      CHRISTOFOROS CHRISTOFI, LEANDROS LAMNIS, ALEXANDRA STARK, HEIKE PALM, KLAUS RÖMER, THOMAS VOGT and JÖRG REICHRATH
      Anticancer Research October 2022, 42 (10) 5049-5067; DOI: https://doi.org/10.21873/anticanres.16014
    • Open Access
      Quantification of Urinary Thymidine Dimers in Volunteers After Ultraviolet Radiation Using a New UPLC-MS/MS-based Method
      CATHARINA M. LERCHE, PETER A. PHILIPSEN, SIGURD HERMANSSON, JAKOB HEYDENREICH and HANS CHRISTIAN WULF
      Anticancer Research October 2022, 42 (10) 5069-5076; DOI: https://doi.org/10.21873/anticanres.16015
    • You have access
      Synthesis of 13C Labeled Vitamin D Metabolites for Their Use in LC-MS/MS: Valuable Tools for Cancer Research and Other Applications
      LARS KATTNER and ERIK RAUCH
      Anticancer Research October 2022, 42 (10) 5077-5081; DOI: https://doi.org/10.21873/anticanres.16016
    • Open Access
      High Oral Vitamin D3 Intake Does Not Protect Against UVR-induced Squamous Cell Carcinoma in Mice
      CATHARINA M. LERCHE, FERNANDA E. PINTO, PETER A. PHILIPSEN, ELISABETH S. BECH, JETTE JAKOBSEN, MERETE HAEDERSDAL and HANS CHRISTIAN WULF
      Anticancer Research October 2022, 42 (10) 5083-5090; DOI: https://doi.org/10.21873/anticanres.16017
    • You have access
      Mosquitoes Exposed to Sunlight in Florida Are Capable of Making Vitamin D3
      MICHAEL F. HOLICK and PHILIP K. STODDARD
      Anticancer Research October 2022, 42 (10) 5091-5094; DOI: https://doi.org/10.21873/anticanres.16018
  • Clinical Studies

    • Open Access
      Evaluation of 14-day Concentration-time Curves of Vitamin D3 and 25-Hydroxyvitamin D3 in Healthy Adults With Varying Body Mass Index
      NIPITH CHAROENNGAM, PETER M. MUELLER and MICHAEL F. HOLICK
      Anticancer Research October 2022, 42 (10) 5095-5100; DOI: https://doi.org/10.21873/anticanres.16019
    • Open Access
      Ultra-low Ultraviolet Radiation in Office Lighting Can Moderate Seasonal Vitamin D Cycle: A Pilot Study
      ANN R. WEBB, BIANCA M.I. VAN DER ZANDE, RICHARD C. KIFT, HELEN O’NEIL, NAN XUAN LIN and DAVID WRIGHT
      Anticancer Research October 2022, 42 (10) 5101-5106; DOI: https://doi.org/10.21873/anticanres.16020

Abstracts of the 32nd Annual Meeting of the Italian Society of Uro-Oncology (SIUrO)

  • Open Access
    Abstracts of the 32nd Annual Meeting of the Italian Society of Uro-Oncology (SIUrO).
    Anticancer Research October 2022, 42 (10) 5107-5164; DOI: https://doi.org/10.21873/anticanres.16021

Corrigendum

  • Open Access
    Corrigendum
    Anticancer Research October 2022, 42 (10) 5165;
Back to top
PreviousNext

In this issue

Anticancer Research: 42 (10)
Anticancer Research
Vol. 42, Issue 10
October 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Recombinant Thrombomodulin Has Anti-tumor Effects and Enhances the Effects of Gemcitabine for Pancreatic Cancer Through G-protein Coupled Receptor 15
  • Retrospective Analysis of Treatment Pathways in Patients With BRAFV600E-mutant Metastatic Colorectal Carcinoma – MORSECRC
  • Surgical Administration of Indocyanine Green in Hepatectomy for Improved Bile Leakage Detection
  • Efficacy of Chemoimmunotherapy in NSCLC Patients With Brain Metastasis With or Without Prior Brain Radiotherapy
  • An Appraisal to Address Health Consequences of Vitamin D Deficiency With Food Fortification and Supplements: Time to Act!
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Vitamin D in Prevention and Therapy and Biologic Effects of Light
    • Reviews
    • Experimental Studies
    • Clinical Studies
  • Abstracts of the 32nd Annual Meeting of the Italian Society of Uro-Oncology (SIUrO)
  • Corrigendum
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire